A feasibility study comparing topical use of acetic acid at the exit site versus mupirocin to prevent exit site infections in peritoneal dialysis patients.
Phase 1
Completed
- Conditions
- Peritoneal dialysis exit site infectionRenal and Urogenital - Kidney diseaseInfection - Other infectious diseases
- Registration Number
- ACTRN12617001286336
- Lead Sponsor
- Mrs Lesley Williams
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
All adult patients undergoing peritoneal dialysis under the catchement area of the Royal Brisbane and Women's Hospital.
No active peritonitits or exit site infection.
Ability to comply with exit site cares.
Exclusion Criteria
Active infection.
Inability to comply with exit site cares.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method